Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul:233:97-98.
doi: 10.1016/j.schres.2021.06.036. Epub 2021 Jun 26.

Letter on: "Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population"

Ahmad Amjed Toubasi  1
Affiliations
Comment

Letter on: "Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population"

Ahmad Amjed Toubasi. Schizophr Res. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Comment on

References

    1. Canal-Rivero M., Catalán-Barragán R., Rubio-García A., Garrido-Torres N., Crespo-Facorro B., Ruiz-Veguilla M. Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: a retrospective epidemiological study in a representative Spanish population. Schizophr. Res. 2021;229:53–54. - PMC - PubMed
    1. Fresán U., Guevara M., Trobajo-Sanmartín C., Burgui C., Ezpeleta C., Castilla J. Hypertension and related comorbidities as potential risk factors for COVID-19 hospitalization and severity: a prospective population-based cohort study. J. Clin. Med. 2021;10(6) - PMC - PubMed
    1. Kirov G., Baker E. 2021. COVID-19 and Mortality Risk in Patients With Psychiatric Disorders. 2021.2004.2008.21255046.
    1. Lenze E.J., Mattar C., Zorumski C.F., Stevens A., Schweiger J., Nicol G.E., Miller J.P., Yang L., Yingling M., Avidan M.S., Reiersen A.M. Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial. JAMA. 2020;324(22):2292–2300. - PMC - PubMed
    1. Mohebbi N., Talebi A., Moghadamnia M., Nazari Taloki Z., Shakiba A. Drug interactions of psychiatric and COVID-19 medications. Basic Clin. Neurosci. 2020;11(2):185–200. - PMC - PubMed